Thromboembolism
Showing 1 - 25 of 2,453
Venous Thromboembolism Trial in Beijing
Recruiting
- Venous Thromboembolism
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences Fuwai Hospital
Oct 5, 2023
Venous Thromboembolism in Primary Pancreatic Tumour Resection
Not yet recruiting
- Venous Thromboembolism
- +2 more
-
Larissa, Thessaly, GreeceUniversity Hospital of Larissa
Jul 27, 2023
Model for Venous Thromboembolism Following Neurosurgery
Recruiting
- Venous Thromboembolism
- +2 more
- Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery
-
Beijing, ChinaSanbo Brain Hospital, Capital Medical University
May 6, 2023
Chemical Venous Thromboembolism Prophylaxis in Trauma
Enrolling by invitation
- Thromboembolism, Venous
-
Dallas, TexasMethodist Dallas Medical Center Pharmacy
Sep 1, 2023
Venous Thromboembolism Trial in Geneve (Enoxaparin)
Completed
- Venous Thromboembolism
-
Geneve, SwitzerlandGeneva University Hospitals
May 24, 2023
Trauma Injury, Thromboembolism, Venous Thromboembolism Trial in Houston (Thrombate infusion, Placebo)
Not yet recruiting
- Trauma Injury
- +2 more
- Thrombate infusion
- Placebo
-
Houston, TexasThe University of Texas Health Science Center at Houston
Mar 28, 2023
Peripartum Anticoagulation manaGement for thrOmboembolism
Not yet recruiting
- Pregnancy Related
- Venous Thromboembolism
-
Calgary, Alberta, CanadaFoothills Medical Centre
Feb 21, 2023
Intimate Partner Violence asRisk Factor for Venous
Recruiting
- Venous Thrombosis
- WAST questionnaire
-
Nîmes Cedex 09, FranceCHU de Nîmes - Hôpital Universitaire Carémea
Jun 9, 2023
Venous Thromboembolism (VTE) Trial (Additional blood sampling)
Not yet recruiting
- Venous Thromboembolism (VTE)
- Additional blood sampling
- (no location specified)
Sep 26, 2023
Transurethral Resection, Wearable Devices, Venous Thromboembolism Trial (Socks Developed with Wearable Technology)
Not yet recruiting
- Transurethral Resection
- +4 more
- Socks Developed with Wearable Technology
- (no location specified)
Jun 2, 2023
Cancer-associated Venous Thromboembolism
Recruiting
- Venous Thromboses
- Neoplasms
-
Wuhan, ChinaTongji Hospital
Feb 6, 2023
Prevention of Venous Thromboembolism After Knee Arthroplasty Trial (SHR-2004 injection, Enoxaparin sodium injection)
Not yet recruiting
- Prevention of Venous Thromboembolism After Knee Arthroplasty
- SHR-2004 injection
- Enoxaparin sodium injection
- (no location specified)
Feb 22, 2023
Compare Health Care Costs Between Apixaban and Low Molecular
Active, not recruiting
- Thromboembolism
-
New York, New YorkPfizer Investigational
Dec 1, 2022
Atrial Fibrillation, Thromboembolism, Venous Trial in Roma (DOACs)
Recruiting
- Atrial Fibrillation
- Thromboembolism, Venous
-
Roma, ItalyFondazione Policlinico Universitario A.Gemelli IRCCS
Feb 20, 2023
Extended Versus Conventional Duration of Enoxaparin Prophylaxis
Not yet recruiting
- Venous Thromboembolism
- (no location specified)
Apr 6, 2023
Venous Thromboembolism and Bleeding Events inPopulation of Obese
Not yet recruiting
- Venous Thromboembolism
- (no location specified)
Apr 6, 2023
Acute Coronary Syndrome Trial in Shatin (CSL112, Placebo)
Not yet recruiting
- Thromboembolism
- No intervention as this is an observational study
-
Shatin, Hong KongThe Chinese University of Hong Kong
Nov 1, 2022
Sarcoma, Soft Tissue Sarcoma, Bone Sarcoma Trial in Boston (Aspirin 325mg, Enoxaparin 40Mg/0.4mL Prefilled Syringe)
Enrolling by invitation
- Sarcoma
- +6 more
- Aspirin 325mg
- Enoxaparin 40Mg/0.4mL Prefilled Syringe
-
Boston, MassachusettsSantiago Lozano-Calderon
Jan 20, 2023
COVID-19 and Venous Thromboembolism Risk
Completed
- Venous Thromboembolism
- Covid19
- Laboratory test positive for SARS-CoV-2 virus
-
Oakland, California
- +1 more
Oct 31, 2022
Safety of Rivaroxaban in Children Under 2 Years Old With Venous
Not yet recruiting
- Venous Thromboembolism
- Children Under 2 Years
- Rivaroxaban (Xarelto, BAY59-7939)
- Standard of care (SOC)
-
Multiple Locations, Denmark
- +3 more
Jun 9, 2023
Venous Thromboembolism, Urologic Cancer Trial (Rivaroxaban 10 MG, Placebo control)
Not yet recruiting
- Venous Thromboembolism
- Urologic Cancer
- Rivaroxaban 10 MG
- Placebo control
- (no location specified)
Jun 16, 2023